Post by account_disabled on Dec 19, 2023 1:18:29 GMT -6
Young invests in companies across the longevity sphere with many falling into the categories of gene editing and therapies organ generation and AI drug discovery. And yes organ generation is exactly what it sounds like: Young says that human bodies of the future will act like antique cars — as internal parts age and stop working they can be replaced with new tech while maintaining the same facade. (Instead of engines organs.
Since aging is not considered a disease the FDA Email Marketing List lacks regulatory processes for approving drugs made to treat it changing the way that researchers entrepreneurs and scientists approach the sector. While we’ve added an additional years to the global life expectancy since living a long life is not the same as living a healthy one and the end of one’s life can cause strain on both individuals and public systems when health is in decline. There are also economic and societal costs associated with longevity. Dr. Arthur Caplan a professor of bioethics at New York University’s School of Medicine says that there are many when weighing the pros and cons of a longer life.
To start professions where turnover is slow could see job shortages as more people are born but fewer retire. There’s also the concern that when those individuals do retire but suddenly have many more years of life post-retirement they can add pressure to already strained social programs — like Medicare — that support older individuals. “There may be more upheaval than you might expect within the health care system. It’s built on a certain premise about a life span ” says Caplan. “When you go to hospice and when you go to physical therapy and when you go to rehab and when you go to a nursing home — they’re age linked.
Since aging is not considered a disease the FDA Email Marketing List lacks regulatory processes for approving drugs made to treat it changing the way that researchers entrepreneurs and scientists approach the sector. While we’ve added an additional years to the global life expectancy since living a long life is not the same as living a healthy one and the end of one’s life can cause strain on both individuals and public systems when health is in decline. There are also economic and societal costs associated with longevity. Dr. Arthur Caplan a professor of bioethics at New York University’s School of Medicine says that there are many when weighing the pros and cons of a longer life.
To start professions where turnover is slow could see job shortages as more people are born but fewer retire. There’s also the concern that when those individuals do retire but suddenly have many more years of life post-retirement they can add pressure to already strained social programs — like Medicare — that support older individuals. “There may be more upheaval than you might expect within the health care system. It’s built on a certain premise about a life span ” says Caplan. “When you go to hospice and when you go to physical therapy and when you go to rehab and when you go to a nursing home — they’re age linked.